WEBSITE BSE:0 NSE: Inc. Year: 2017 Industry: Dyes & Pigments
Last updated: 00:00
Yasons Chemex Care Limited is an Indian company engaged in the manufacturing and distribution of chemical products, primarily serving industries such as pharmaceuticals, agriculture, textiles, and industrial manufacturing. The company focuses on producing specialty chemicals, intermediates, and raw materials that are used in various industrial applications. Operating on a modest scale, Yasons Chemex Care emphasizes quality control, regulatory compliance, and building strong relationships with its clients and suppliers. Its business performance ...Read More
Yasons Chemex Care Limited is an Indian company engaged in the manufacturing and distribution of chemical products, primarily serving industries such as pharmaceuticals, agriculture, textiles, and industrial manufacturing. The company focuses on producing specialty chemicals, intermediates, and raw materials that are used in various industrial applications. Operating on a modest scale, Yasons Chemex Care emphasizes quality control, regulatory compliance, and building strong relationships with its clients and suppliers. Its business performance is influenced by raw material price fluctuations, demand from end-use sectors, and market competition. The company’s future growth depends on expanding its product portfolio, enhancing production capabilities, and capitalizing on opportunities in India’s growing chemical and allied industries. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹23 Cr.
Stock P/E 14.3
P/B 0.6
Current Price ₹12
Book Value ₹ 21.1
Face Value 10
52W High ₹18.4
Dividend Yield 0%
52W Low ₹ 10.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|
| Net Sales | 37 | 69 | 77 | |
| Other Income | 4 | 1 | 3 | |
| Total Income | 41 | 70 | 80 | |
| Total Expenditure | 36 | 67 | 76 | |
| Operating Profit | 5 | 4 | 4 | |
| Interest | 0 | 1 | 1 | |
| Depreciation | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | |
| Profit Before Tax | 4 | 2 | 2 | |
| Provision for Tax | 1 | 1 | 1 | |
| Profit After Tax | 3 | 1 | 2 | |
| Adjustments | 0 | -0 | -0 | |
| Profit After Adjustments | 3 | 1 | 2 | |
| Adjusted Earnings Per Share | 2.4 | 0.6 | 0.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 0% | 0% | 0% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 100% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -33% | NA% | NA% | NA% |
| ROE Average | 4% | 8% | 8% | 8% |
| ROCE Average | 7% | 12% | 12% | 12% |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Shareholder's Funds | 21 | 39 | 41 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 1 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | 0 |
| Total Current Liabilities | 6 | 15 | 18 |
| Total Liabilities | 28 | 55 | 59 |
| Fixed Assets | 1 | 3 | 3 |
| Other Non-Current Assets | 7 | 0 | 0 |
| Total Current Assets | 20 | 51 | 56 |
| Total Assets | 28 | 55 | 59 |
| #(Fig in Cr.) | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 1 |
| Cash Flow from Operating Activities | -0 | -16 | -2 |
| Cash Flow from Investing Activities | 0 | -0 | -0 |
| Cash Flow from Financing Activities | 0 | 18 | 1 |
| Net Cash Inflow / Outflow | 0 | 1 | -1 |
| Closing Cash & Cash Equivalent | 0 | 1 | 0 |
| # | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Earnings Per Share (Rs) | 2.42 | 0.64 | 0.83 |
| CEPS(Rs) | 2.49 | 0.87 | 1.04 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 14.63 | 20.24 | 21.07 |
| Core EBITDA Margin(%) | 1.34 | 3.76 | 1.35 |
| EBIT Margin(%) | 12.58 | 4.53 | 4.79 |
| Pre Tax Margin(%) | 11.46 | 2.61 | 2.91 |
| PAT Margin (%) | 9.32 | 1.8 | 2.12 |
| Cash Profit Margin (%) | 9.6 | 2.42 | 2.61 |
| ROA(%) | 12.43 | 3.04 | 2.85 |
| ROE(%) | 16.54 | 4.17 | 4.06 |
| ROCE(%) | 19.12 | 8.73 | 7.37 |
| Receivable days | 113.06 | 105.67 | 140.31 |
| Inventory Days | 79.95 | 60.57 | 81.95 |
| Payable days | 30.03 | 21.45 | 23.71 |
| PER(x) | 0 | 40.14 | 15.39 |
| Price/Book(x) | 0 | 1.27 | 0.61 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.48 | 0.82 | 0.45 |
| EV/Core EBITDA(x) | 3.71 | 15.96 | 8.58 |
| Net Sales Growth(%) | 0 | 88.3 | 10.53 |
| EBIT Growth(%) | 0 | -32.25 | 16.99 |
| PAT Growth(%) | 0 | -63.6 | 29.91 |
| EPS Growth(%) | 0 | -73.44 | 29.88 |
| Debt/Equity(x) | 0.17 | 0.22 | 0.27 |
| Current Ratio(x) | 3.32 | 3.4 | 3.04 |
| Quick Ratio(x) | 2 | 2.4 | 1.99 |
| Interest Cover(x) | 11.26 | 2.36 | 2.55 |
| Total Debt/Mcap(x) | 0 | 0.17 | 0.45 |
| # | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoter | 51.47 | 51.47 | 51.47 | 51.47 | 51.47 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 48.53 | 48.53 | 48.53 | 48.53 | 48.53 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoter | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 1.93 | 1.93 | 1.93 | 1.93 | 1.93 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
